# Smith Midland Corp: overview SMID · Nasdaq · CIK 924719 · [Materials](/sectors/materials.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/smid.md) · [Financials](/companies/smid/financials.md) · [Filings](/companies/smid/filings.md) · [Insiders](/companies/smid/insiders.md) Latest reported revenue: [$23.4m](/filings/0001654954-26-007660.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 14, 2026 (XBRL us-gaap:Revenues, accession 0001654954-26-007660). ## Last eight quarters | Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [23.6](/filings/0001654954-25-013097.md) | [18.5 d](/filings/0001654954-26-003505.md) | [22.7](/filings/0001654954-26-005829.md) | [26.2](/filings/0001654954-26-007660.md) | [21.5](/filings/0001654954-25-013097.md) | [23.1 d](/filings/0001654954-26-003505.md) | [21.6](/filings/0001654954-26-005829.md) | [23.4](/filings/0001654954-26-007660.md) | | Gross margin | % | [27.9%](/filings/0001654954-25-013097.md) | [23.7% d](/filings/0001654954-26-003505.md) | [30.7%](/filings/0001654954-26-005829.md) | [29.7%](/filings/0001654954-26-007660.md) | [26.8%](/filings/0001654954-25-013097.md) | [23.9% d](/filings/0001654954-26-003505.md) | [19.9%](/filings/0001654954-26-005829.md) | [23.2%](/filings/0001654954-26-007660.md) | | Operating margin | % | [16.3%](/filings/0001654954-25-013097.md) | [10.1% d](/filings/0001654954-26-003505.md) | [19.3%](/filings/0001654954-26-005829.md) | [21.1%](/filings/0001654954-26-007660.md) | [18.0%](/filings/0001654954-25-013097.md) | [14.0% d](/filings/0001654954-26-003505.md) | [8.0%](/filings/0001654954-26-005829.md) | [8.5%](/filings/0001654954-26-007660.md) | | Net margin | % | [13.4%](/filings/0001654954-25-013097.md) | [7.5% d](/filings/0001654954-26-003505.md) | [14.7%](/filings/0001654954-26-007660.md) | [15.9%](/filings/0001654954-26-007660.md) | [13.4%](/filings/0001654954-25-013097.md) | [9.2% d](/filings/0001654954-26-003505.md) | [6.2%](/filings/0001654954-26-007660.md) | [5.9%](/filings/0001654954-26-007660.md) | | Diluted EPS | $ per share | [0.59](/filings/0001654954-25-013097.md) | not reported | [0.62](/filings/0001654954-26-005829.md) | [0.79](/filings/0001654954-26-007660.md) | [0.54](/filings/0001654954-25-013097.md) | not reported | [0.25](/filings/0001654954-26-005829.md) | [0.26](/filings/0001654954-26-007660.md) | | Free cash flow | $m | [0.3 d](/filings/0001654954-25-013097.md) | [(1.3) d](/filings/0001654954-26-003505.md) | [1.6](/filings/0001654954-26-005829.md) | [(2.8) d](/filings/0001654954-25-009560.md) | [6.3 d](/filings/0001654954-25-013097.md) | [(1.4) d](/filings/0001654954-26-003505.md) | [1.5](/filings/0001654954-26-005829.md) | [(2.4) d](/filings/0001654954-26-007660.md) | - Revenue. XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure. ## Last five fiscal years | Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [50.6](/filings/0001654954-23-004852.md) | [50.1](/filings/0001654954-24-006855.md) | [59.6](/filings/0001654954-25-006144.md) | [78.5](/filings/0001654954-26-003505.md) | [93.4](/filings/0001654954-26-003505.md) | | Gross margin | % | [28.5%](/filings/0001654954-23-004852.md) | [18.9%](/filings/0001654954-24-006855.md) | [17.9%](/filings/0001654954-25-006144.md) | [25.5%](/filings/0001654954-26-003505.md) | [27.9%](/filings/0001654954-26-003505.md) | | Operating margin | % | [12.2%](/filings/0001654954-23-004852.md) | [1.7%](/filings/0001654954-24-006855.md) | [1.9%](/filings/0001654954-25-006144.md) | [12.6%](/filings/0001654954-26-003505.md) | [18.2%](/filings/0001654954-26-003505.md) | | Net margin | % | [14.9%](/filings/0001654954-23-004852.md) | [1.6%](/filings/0001654954-24-006855.md) | [1.3%](/filings/0001654954-25-006144.md) | [9.8%](/filings/0001654954-26-003505.md) | [13.4%](/filings/0001654954-26-003505.md) | | Diluted EPS | $ per share | [1.45](/filings/0001654954-23-004852.md) | [0.15](/filings/0001654954-24-006855.md) | [0.15](/filings/0001654954-25-006144.md) | [1.45](/filings/0001654954-26-003505.md) | [2.36](/filings/0001654954-26-003505.md) | | Free cash flow | $m | [3.8](/filings/0001654954-23-004852.md) | [(9.1)](/filings/0001654954-24-006855.md) | [2.7](/filings/0001654954-25-006144.md) | [(1.0)](/filings/0001654954-26-003505.md) | [5.0](/filings/0001654954-26-003505.md) | - Revenue. XBRL Revenue: us-gaap:Revenues. - Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:Revenues. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/smid/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [THOMPSON DAVIS & CO., INC.](/funds/1017284.md) | 2026-06-30 | $52.9m | 1,824,119 | | Reduced −17,656 | | [NEEDHAM INVESTMENT MANAGEMENT LLC](/funds/1167212.md) | 2026-06-30 | $6.5m | 225,000 | | Unchanged | | [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $5.7m | 196,437 | | Added +35,330 | | [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $4.0m | 137,332 | | Reduced −42,981 | | [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $2.6m | 89,742 | | Added +6,842 | | [BARD ASSOCIATES INC](/funds/1105907.md) | 2026-06-30 | $2.3m | 79,875 | | Reduced −458 | | [RBF Capital, LLC](/funds/1134621.md) | 2026-06-30 | $2.2m | 74,200 | | Unchanged | | [RICE HALL JAMES & ASSOCIATES, LLC](/funds/1230765.md) | 2026-06-30 | $1.6m | 53,979 | | Added +2,633 | | [DIMENSIONAL FUND ADVISORS LP](/funds/354204.md) | 2026-06-30 | $1.5m | 50,555 | | Added +5,826 | | [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $1.3m | 45,713 | | Reduced −520 | ## Recent filings [All 428 filings](/companies/smid/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-10-07 | 20:13 ET | [SCHEDULE 13D/A](/filings/0001017284-26-000010.md) | Ownership report, active investor, amended | 0001017284-26-000010 | | 2026-08-25 | 20:07 ET | [8-K](/filings/0001654954-26-007861.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001654954-26-007861 | | 2026-08-14 | 20:31 ET | [10-Q](/filings/0001654954-26-007660.md) | Quarterly report, period 2026-06-30 | 0001654954-26-007660 | | 2026-08-14 | 20:16 ET | [8-K](/filings/0001654954-26-007658.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001654954-26-007658 | | 2026-07-23 | 22:04 ET | [8-K](/filings/0001654954-26-006796.md) | 5.07 Shareholder vote results | 0001654954-26-006796 | | 2026-06-11 | 23:48 ET | [8-K](/filings/0001654954-26-005864.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001654954-26-005864 | | 2026-06-10 | 21:34 ET | [10-Q](/filings/0001654954-26-005829.md) | Quarterly report, period 2026-03-31 | 0001654954-26-005829 | | 2026-06-09 | 20:30 ET | [8-K](/filings/0001654954-26-005827.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001654954-26-005827 | | 2026-06-04 | 22:00 ET | [8-K](/filings/0001654954-26-005673.md) | 3.01 Delisting notice; 9.01 Financial statements and exhibits | 0001654954-26-005673 | | 2026-06-02 | 20:33 ET | [DEF 14A](/filings/0001654954-26-005625.md) | Proxy statement, period 2026-06-01 | 0001654954-26-005625 | ## Latest annual report [Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001654954-26-003505.md), filed Apr 14, 2026. ## Forecast league Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/b4291302-b433-43b0-b71c-920e4f5575bb) ## About the filer - CIK: 924719 - Tickers: SMID - Exchange: Nasdaq - SIC code: 3272 Concrete Products, Except Block & Brick - State of incorporation: DE - Filer category: Non-accelerated filer
Smaller reporting company Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:29 ET. No prices; not investment advice.